A Study of Single and Repeat Dose Administration of UBX0101 in Patients With Osteoarthritis of the Knee

NCT04229225 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Knee Osteoarthritis

Interventions

DRUG: UBX0101
OTHER: Placebo

Sponsor

Unity Biotechnology, Inc.